Editas Medicine, Inc.
Длинная

Crispr is here to stay

Обновлено
Looks like a lot studies are reporting positive news, I think there is going to rally within crispr stocks.
Сделка закрыта: достигнута тейк-профит цена
Seems like we have had reached the target earlier than expected. I would recommend to take partial profit here.
Trend Analysis

Отказ от ответственности